Location: Palo Alto, CA
CIK: 0001664974 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $226M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OKLO | Oklo Inc. | 5,277,513 | $112M | 49.5% | $11.25 | +72.3% | COM CL A | 02156V109 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $40.16M | 17.7% | $18.82 | -64.3% | CL A | 75629V104 |
| EVLV | Evolv Technologies Holdings, Inc. | 9,681,281 | $38.24M | 16.9% | $5.61 | -37.5% | COM CL A | 30049H102 |
| — | Rocket Lab USA, Inc. | 1,377,943 | $35.1M | 15.5% | $4.04 | — | COM | 773122106 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $698K | 0.3% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $45,841 | 0.0% | $5.56 | +112.5% | SHS | G76279101 |